Association of Lipoprotein(a) with PAD De Novo and Major Adverse Cardiovascular and Limb Events

Background/objective: To investigate the association between lipoprotein(a) (Lp(a)) concentrations, peripheral arterial disease (PAD), and the occurrence of major adverse cardiovascular events (MACE), or major adverse limb events (MALE). Methods: This prospective single center cohort study included 475 patients referred to a vascular center with suspected PAD de novo between January 13th 2017 and December 27th 2019. Serum Lp(a) concentrations were measured at baseline, and electronic patients’ records were reviewed for diagnosis of PAD at baseline, and the occurrence of MACE or MALE during follow-up. MACE was defined as a composite of myocardial infarction, unplanned percutaneous coronary intervention, ischemic cerebrovascular accident, transient ischemic attack, and cardiovascular death. MALE was defined as any endovascular or open revascularization or limbrelated vascular intervention performed due to PAD. Results: Of the 475 patients, 332 patients (69.9%) were diagnosed with PAD. Patients with PAD had significantly higher median LP(a) concentrations compared to those in whom PAD was ruled out (30 [11-77] mg/dL versus 19 [9-64] mg/dL, p=0.033), without differences in other lipid parameters. During a median follow-up of 6 years, 81 patients with PAD (24.4%) experienced MACE, and 141 patients (42.5%) experienced MALE. Univariate cox regression analysis showed that serum Lp(a) concentration was not significantly associated with MACE (HR 0.909, p=0.206), nor MALE (HR 1.000, p=0.995) in patients with PAD. Multivariate cox regression showed similar results. Conclusion: Patients who were diagnosed with PAD de novo had significantly higher Lp(a) concentrations, but Lp(a) was not significantly associated with occurrence of MACE or MALE.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-18
DOI
https://doi.org/10.20944/preprints202611.1905.v1
Primary Topic
Peripheral Artery Disease Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Association of Lipoprotein(a) with PAD De Novo and Major Adverse Cardiovascular and Limb Events

Lars L. F. G. Valke, Michel M.P.J. Reijnen, Houshang Monajemi, Josephine Kranendonk et al.
Preprints.org
Peripheral Artery Disease Management
preprint

Association of Lipoprotein(a) with PAD De Novo and Major Adverse Cardiovascular and Limb Events

Lars L. F. G. Valke, Michel M.P.J. Reijnen, Houshang Monajemi, Josephine Kranendonk, Michiel C. Warlé, Suzanne Holewijn, C. Kramers
preprint en

Abstract

Background/objective: To investigate the association between lipoprotein(a) (Lp(a)) concentrations, peripheral arterial disease (PAD), and the occurrence of major adverse cardiovascular events (MACE), or major adverse limb events (MALE). Methods: This prospective single center cohort study included 475 patients referred to a vascular center with suspected PAD de novo between January 13th 2017 and December 27th 2019. Serum Lp(a) concentrations were measured at baseline, and electronic patients’ records were reviewed for diagnosis of PAD at baseline, and the occurrence of MACE or MALE during follow-up. MACE was defined as a composite of myocardial infarction, unplanned percutaneous coronary intervention, ischemic cerebrovascular accident, transient ischemic attack, and cardiovascular death. MALE was defined as any endovascular or open revascularization or limbrelated vascular intervention performed due to PAD. Results: Of the 475 patients, 332 patients (69.9%) were diagnosed with PAD. Patients with PAD had significantly higher median LP(a) concentrations compared to those in whom PAD was ruled out (30 [11-77] mg/dL versus 19 [9-64] mg/dL, p=0.033), without differences in other lipid parameters. During a median follow-up of 6 years, 81 patients with PAD (24.4%) experienced MACE, and 141 patients (42.5%) experienced MALE. Univariate cox regression analysis showed that serum Lp(a) concentration was not significantly associated with MACE (HR 0.909, p=0.206), nor MALE (HR 1.000, p=0.995) in patients with PAD. Multivariate cox regression showed similar results. Conclusion: Patients who were diagnosed with PAD de novo had significantly higher Lp(a) concentrations, but Lp(a) was not significantly associated with occurrence of MACE or MALE.

Preprints.org
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon